![Amin Kamel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amin Kamel
No open positions remaining
Profile
Amin Kamel formerly worked at Takeda Pharmaceuticals International, Inc., as Scientific Director and Regulus Therapeutics, Inc., as Vice President-DMPK from 2022 to 2025.
Dr. Kamel received his doctorate degree from the University of Rhode Island.
Former positions of Amin Kamel
| Companies | Position | End |
|---|---|---|
| REGULUS THERAPEUTICS INC. | Corporate Officer/Principal | 25/06/2025 |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Chief Tech/Sci/R&D Officer | - |
Training of Amin Kamel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
18
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
University of Rhode Island
 University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Commercial Services |
- Stock Market
- Insiders
- Amin Kamel
